172 related articles for article (PubMed ID: 16496170)
1. LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor.
Favretto D; Frison G; Maietti S; Ferrara SD
Int J Legal Med; 2007 Jul; 121(4):259-65. PubMed ID: 16496170
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.
Jang M; Kim J; Han I; Yang W
J Pharm Biomed Anal; 2015 Nov; 115():138-43. PubMed ID: 26188861
[TBL] [Abstract][Full Text] [Related]
3. Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine.
Chung A; Hudson J; McKay G
J Anal Toxicol; 2009 Jun; 33(5):253-9. PubMed ID: 19671244
[TBL] [Abstract][Full Text] [Related]
4. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
Sklerov JH; Magluilo J; Shannon KK; Smith ML
J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
[TBL] [Abstract][Full Text] [Related]
6. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
Mardal M; Johansen SS; Thomsen R; Linnet K
Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
[TBL] [Abstract][Full Text] [Related]
7. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL
J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
[TBL] [Abstract][Full Text] [Related]
8. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
Verstraete AG; Van de Velde EJ
Acta Clin Belg; 1999; 53 Suppl 1():94-6. PubMed ID: 10216992
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.
Steuer AE; Poetzsch M; Stock L; Eisenbeiss L; Schmid Y; Liechti ME; Kraemer T
Drug Test Anal; 2017 May; 9(5):788-797. PubMed ID: 27422082
[TBL] [Abstract][Full Text] [Related]
10. LSD in pubic hair in a fatality.
Gaulier JM; Maublanc J; Lamballais F; Bargel S; Lachâtre G
Forensic Sci Int; 2012 May; 218(1-3):25-7. PubMed ID: 22019391
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
Johansen SS; Jensen JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):21-8. PubMed ID: 16154519
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
Dolder PC; Liechti ME; Rentsch KM
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
[TBL] [Abstract][Full Text] [Related]
13. Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption.
Ng XQ; Goh EML; Hamzah A; Yao YJ; Moy HY
J Anal Toxicol; 2024 Jun; 48(5):281-288. PubMed ID: 38613436
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
Dolder PC; Liechti ME; Rentsch KM
Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574
[TBL] [Abstract][Full Text] [Related]
15. Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS.
Berg T; Jørgenrud B; Strand DH
J Anal Toxicol; 2013 Apr; 37(3):159-65. PubMed ID: 23423312
[TBL] [Abstract][Full Text] [Related]
16. Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry.
Canezin J; Cailleux A; Turcant A; Le Bouil A; Harry P; Allain P
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):15-27. PubMed ID: 11817305
[TBL] [Abstract][Full Text] [Related]
17. The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.
Poch GK; Klette KL; Anderson C
J Anal Toxicol; 2000 Apr; 24(3):170-9. PubMed ID: 10774536
[TBL] [Abstract][Full Text] [Related]
18. LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex PolyChrom CLIN II columns.
Horn CK; Klette KL; Stout PR
J Anal Toxicol; 2003 Oct; 27(7):459-63. PubMed ID: 14607000
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.
del Mar Ramirez Fernandez M; Laloup M; Wood M; De Boeck G; Lopez-Rivadulla M; Wallemacq P; Samyn N
J Anal Toxicol; 2007 Oct; 31(8):497-504. PubMed ID: 17988464
[TBL] [Abstract][Full Text] [Related]
20. Determination of LSD in urine with high-performance liquid chromatography--mass spectrometry.
Bodin K; Svensson JO
Ther Drug Monit; 2001 Aug; 23(4):389-93. PubMed ID: 11477321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
